All News

A&P and Pathmark merger near

Evidence of fetal risk reported for mycophenolic acid (Myfortic, Novartis)

Software manages and tracks every IV dose administered by hospitals

FDA, Bodee LLC issue nationwide recall of Encore Tablets

FDA, Bodee LLC issue nationwide recall of Encore Tablets

Telephone and on-line directory company YellowPages is creating an on-line directory of pharmacies.

DEA proposes a rule that would create a new format for ordering Schedule I and/or II controlled substances.

Beginning January 2009, computer-generated fax prescriptions will no longer be exempted from the requirement to meet the NCPDP SCRIPT standard according to CMS.

NIH to meet over use of hydroxyurea for sickle cell disease

National influenza vaccination week encourages flu vaccinations

More pediatric patients can now use Omnaris Nasal Spray for hay fever

Duane Reade has to pay thousands of dollars in restitution for selling expired over-the-counter products

Supervalu is offering glucose screenings during the holiday season

CMS has selected WellPoint to administer its point-of-sale Part D enrollment program for low-income subsidized Medicare beneficiaries.

FDA issues new information on varenicline (Chantix, Pfizer)

92 new products in development for HIV/AIDS

Aripiprazole approved for depression

Fougera donates topical steroids and antibiotics to countries in need via AmeriCares

Schering-Plough/Organon merger passes antitrust scrutiny and is completed

Many Medicare Part D patients will find fewer drugs to choose from in their drug plans' formularies in 2008

Seroquel XR from AstraZeneca has gained a new indication: for maintenance treatment of schizophrenia in adults

DEA has released its final rule allowing doctors to give patients multiple prescriptions for up to a 90-day supply of Schedule II narcotics

Mother sues drugmakers over son's cold medication death

Nexavar gains new indication approval for liver cancer

The American Society of Consultant Pharmacists has selected PharmMD Solutions as a medication therapy management provider partner

FDA says product contains unapproved drug and could damage eye

Pharmacy schools' emphasis on chemistry is unjustified, according to this community pharmacist.

New products include brand-name drugs, generics, home-health products, over-the-counter, and health and beauty care.